SlideShare uma empresa Scribd logo
1 de 54
Baixar para ler offline
Quality Of Medical Care for Patients With
 Mental Illness -

 Do Our Patients Get A Raw Deal?


Alex Mitchell
Oliver Lord

Acknowledgements
Darren Malone
Caroline Carney-Doebbling
Nasser Abdelmawla
Brett Thombs
Roy Ziegelstein                     Open meeting Jan 2010
                                    Open meeting Jan 2010
Contents
 1. Mental Health & Physical Health
    Comorbidity & Mortality

 2. Preventive Health Care Inequality
    Screening & prevention

 3. Medical Health Care Inequality
    Procedures & prescribing

 4. Implications for mortality
    Linking poor quality of care with mortality

 5. Who is Monitoring?
    Guidelines & responsibility

 6. Can inequalities be Improved?
    Interventions
1. Physical Health Comorbidity / Mortality
Comorbid Physical Diagnoses in Elderly Depressed
                                Patients
80

70

60

50

40

30

20

10

0
         One               Tw o            Three+              None



 Proctor EK, et al (2003) American Journal of Geriatric Psychiatry;11:329-
 38.
40

                                                  P hysical C omorbidity in S chiz ophrenia and D epression
35


30
                                                                                                                                                    Schizophrenia
                                                                                                                                                    Depression
25
                                                                                                                                                    NHANES

20


15


10                                                                                                                                                                                                                                                                   Sokal 2004
                                                                                                                                                                                                                                                                 J Nerv Ment Dis 192:
                                                                                                                                                                                                                                                                         421– 427
 5


 0




                                                                                                                                                                                                                                                                     Angina
                                                                Ulcer




                                                                                               Heart condition




                                                                                                                                  Any cancer
                                         Asthma


                                                     Diabetes
                    Chronic bronchitis




                                                                                                                                               Stroke


                                                                                                                                                        Emphysema




                                                                                                                                                                                                                                         Myocardial infarction
     Hypertension




                                                                        Rheumatoid arthritis




                                                                                                                 Osteoarthritis




                                                                                                                                                                                                                                                                              Coronary heart
                                                                                                                                                                                     Weak/failing kidneys


                                                                                                                                                                                                            Congestive heart
                                                                                                                                                                    Liver problems




                                                                                                                                                                                                                                                                                               disease
                                                                                                                                                                                                                               failure
NHANES - US Department of Health National Health and Nutrition Examination Survey , 1988 –1994
Maine Study Results:
Comparison of Health Disorders Between SMI & Non-SMI Groups
            of Health Disorders Between


                                  80
                                                                                                                                   SMI (N=9224)
                                  70
                                         59.4                                                                                      Non-SMI (N=7352)
                                  60
      P e rc e n t M e m b e rs




                                  50
                                  40                33.9
                                                               30      28.6      28.4
                                  30                                                       22.8      21.7
                                  20                                                                           16.5
                                                                                                                        11.5      11.1
                                  10                                                                                                         6.3       5.9

                                   0
                                             Sk            Ga          Ob          CO         In    Hy         De      D           C    He        Pn       L iv
                                                  el e        st r        es           P D f ect       pe        nt a iab e an c          ar t        eu        e
                                                       tal         o-I       it y                iou      rt e       lD        tes   er        D is      mo r Di
                                                          -C          nte         /D y               s D nsi o          iso                         ea     n         se
                                                             on
                                                                 ne       sti         sl i
                                                                                          pid           ise       n         rd e                       se ia/ In f ase
                                                                     cti nal                                 ase                 rs                               l ue
                                                                                                                                                                       nz
                                                                        ve                                                                                                a


                                       Colton CW, Manderscheid RW. Prev Chronic Dis [serial online] 2006 Apr [date cited]. Available from:
                                                                                                                                     from:
                                       URL:http://www.cdc.gov/pcd/issues/2006/apr/05_0180.htm
Lawrence & Coghlan N S W Public Health Bull 2002; 13(7): 155–158 n=240,000
Mortality and Depression - IHD




                                 Psychosomatic Med (2004) Barth et al
Schizophrenia – all cause mortality

                                      >
                                      >
                                      >




                                                 >




                                          Saha (2007) AGP




Pooled estimate=2.50
 (95% CI=2.18-2.83)
Five-year Mortality rates

    30                   People with schizophrenia                     28%

                         People without schizophrenia
    25
               22%

    20                                 19%


    15
                                                                                 12%

    10                                           9%
                      8%


     5

     0
                  CHD                   Diabetes                          Stroke




Hippisley-Cox J et al (2006) A comparison of survival rates for people with mental health
problems and the remaining population with specific conditions.
Disability Rights Commission. Equal treatment: closing the gap, July 2006

                                             Slide credit: Dr Alan Farmer, Worcestershire Mental Health Partnership NHS Trust
Mortality & Mental illness: Caveat


 Has the mortality gap been reducing?

 Has modern medication improved the situation?
Mortality Trends
Mortality Trends
Effect of Medication
 Varies according to

        Schizophrenia

        Dementia

        Depression
Smoller et al (2010) Ann Int Med

SSRI associated with increased all-cause mortality
  HR 1.32 95% CI, 1.10-1.59


SSRI associated with increased stroke
  HR   1.45, 95% CI, 1.08-1.97


TCA associated with increased risk of all-cause mortality
  HR,1.67 [95% CI, 1.33-2.09
Mental Illness => High Medical Morbidity & Mortality

 Therefore do we?

   i Improve preventive screening

   ii Enhance quality of routine medical care

   iii Ensure adequate physical health medication

   iv Help with treatment adherence (NICE)

   v Monitor physical health issues
2. Preventive Health Care Inequality
Screening activities
    Mammography => use as an example (over)

    Pap. Smear

    Vaccinations

    Lifestyle counselling

    Blood pressure

    Bowel cancer screening

    Breast examination

    PSA

    Osteoporosis

    Hepatitis & HIV
Mammography
USPSTF recommendations
   Screening mammography with or without clinical breast exam (CBE) every
      1-2 years starting at age 40
   Insufficient evidence for or against CBE alone

UK NSC (England)
   Age 50-70 every 3 years
Mammography and Depression
Over 40 years
   Druss (2008)US n= OR of not having mammogram
            OR 1.22 (95% CI 1.18-1.26).
       This difference was even greater if the depression was untreated
            adj.OR 1.32 ( 1.22- 1.42).
       Those being treated in secondary care were more likely to have not had
         a mammogram than those treated in primary care
            adjusted OR 1.22(95% CI 1.03-1.44).
   Pirraglia (2004) US n=3302
       Those who screened positive for depression were less likely to have a
         mammogram in the subsequent year adj. OR 0.84 (95% CI 0.73-0.97).
   Stecker et trend to increased use in Depression vs Hypertensive controls
   Green and Pope, US 2000, n=589
        showed increased rates of mammography
Over 65 year olds
       2 US studies showing no difference n=3864
Over 50 year olds
       Canadian study showed no difference, n =1,868
       European study showed no difference, n = 15,380
Mammography and any mental disorder
Werenke (2006) UK n= 533,340
    no difference for mental health service users
    but those on enhanced care were less likely to attend (OR 0.4 95% CI 0.29-
       0.55).
    more than 2 admissions to a mental health hospital were less likely to attend
       for mammography
      (OR 0.65, 95% CI, 0.49-0.85).
Carney and Jones (2006) US n= 191356,
    5 year study period:
         high risk OR 0.38 (95% CI 0.33-0.43),
         moderate risk 0.62 (95% CI 0.59-0.66).
    last 2 years:
         low risk 0.95(95% CI 0.92-.99),
         moderate risk OR 0.71 (95% CI 0.66-0.75),
         high risk OR 0.63 (95% CI 0.53-0.75).
Lasser (2003) US n=526 no difference for mammography in last 2 years

Steiner (1998) US n=64 no difference

Iezzoni (2001) US n=11399 a trend to reduced use of mammography (SMI)
   in the last 2 yrs OR 0.6 (95% CI 0.4 – 1.1)
Mammography and Schizophrenia
Chochinov (2009) Canada n=110,240
     In comparison to the general population (without schizophrenia)
       (n=108,792), women with schizophrenia (n=1448)
     OR 0.64 of mammography in the selected two year period.
Carney and Jones (2006) n=191,356
    No difference over five years
    less likely in the last two years
         OR 0.31 (95% CI 0.12-0.83).
Werenke (2006) UK n= 533,340
    Those with a diagnosis of psychosis were the least likely to attend for
       mammography
    OR 0.33 (95% CI 0.18-0.61)
Lindamer (2003) US n=116
    (Convenience sample) in last 2 years
         68% of women with psychotic disorder
         98% of respondents to advertisement
Druss (2002) US
    less likely to have had a mammogram in last 2 years (for women aged 50-69
       years) adjusted
         OR 0.78(95% CI 0.67-0.91).
3. Medical Health Care Inequality

     Medical monitoring eg HBA1c

     Medical procedures eg CABG

     Medical prescribing eg Insulin
Quality of Care MI vs No MI

27 examined receipt of medical care in
  those with and without mental illness

   19/27 showed deficits in care


10 examined medical care in those with
  and without substance use disorder
  (or dual-diagnosis

   10/10 showed deficits in care
Relevant Primary Data Studies


                                                                                                 26 studies




                  1 study                                2 studies                             10 studies                         9 studies                         4 studies

Studies examining Cancer                 Studies examining                     Studies examining                 Studies examining                  Studies examining
          Care                               HIV Care                            Diabetes Care                   Cardiovascular care               General Medical Care


   Goodwin JS et al. 2004           Palepu A et al. 2006. J Sub Abuse            Desai M et al. 2002                Druss B et al 2000.         Redelmeier D et al. 1998 N Eng J
     JAGS 52; 106-111.                      Treat. In Press *                 Am J Psych. 159;1584-90 *            JAMA 283; 506-511 *               Med. 338; 1516-1520



                                     Bogart et al 2006 AIDS Patient        Lin EH et al. 2004 Diabetes Care         Young J et al 2000.         Desai M et al. 2002 J Gen Intern
                                      Care & STDs 20(3) 175-182                     27(9):2154-60.                  JAMA 28, 3198-9 *                  Med.17; 556-560 *



                                                                              Dixon L 2004. Psychiatric       Druss BD et al. 2001. Arch Gen      Cradock-O’Leary,et al 2002.
                                                                               services. 55;892-900 ª              psych. 58; 565-572 *             Psychia Serv 53;874-8 *



                                                                             Jones L et al. 2004. Medical         Desai MM, et a; 2002.             Dickerson F et al 2003
                                                                                 care.42;1167-1175                JNMD 190(1), 51-53 *           Psychiatric Serv 41; 560-570.



                                                                             Frayne S et al. 2006.Arch Int        Lawrence D et al 2003.
                                                                                 med. 165;2631-2638                Br J Psych 182;31-36.



                                                                             Krein et al 2006 Psychia Serv       Petersen LA et al 2003
                                                                                     57:1016–1021               Health Serv Res 38; 41-63.



                                                                            Sullivan et al. 2006 Psychiatr    Jones L et al. 2005. Psychosom
                                                                                  Serv 57:1126–1131                  Med 67; 568-76.



                                                                                 Weiss AP. et al 2006              Wang P et al. 2005.
   * Studies reporting substance                                            Psychiatr Serv 57(8):1145-1152      Hypertension. 46; 273-279
    abuse and/or mental illness

                                                                               Kreyenbuhl J et al 2006        Hippisley-Cox et al. 2007 Heart
                                                                                 JNMD 194:404–410 ª                    93:1256–1262

  a Studies reporting on the same
              data set
                                                                              Goldberg RW et al. 2007
                                                                             Psychiatr Serv 58:536–543 ª
Quality of Medical Treatment i Procedures
Meta-Analysis of Procedure Rate (PCI) after Myocardial Infarction




 Any Mental illness
HR = 0.86 (0.80-0.92)
Meta-Analysis of Procedure Rate (PCI) after Myocardial Infarction




   Schizophrenia
HR = 0.53 (0.44 – 0.64)
Quality of Medical Treatment i Medication
Inequality of Prescribed Meds ii Medication by Diagnosis

     OR =0.92          OR =0.68            OR =0.72




       SMI                Schz               Affective
Inequality of Prescribed Meds ii Medication by Drug

                                                 OR =0.99
OR =0.79
                                                       ns




OR =0.83                                         OR =0.84
                                                       ns
Quality of Medical Treatment ii Medication by Drug

OR =0.94                                        OR =0.96
ns
4. Implication for Mortality
5. Who Is Monitoring Physical Issues?

     Medical Colleagues

     Mental health

     Primary care
Disparities in care: impact of mental illness on diabetes
management

  Depression

      Anxiety


   Psychosis


       Mania

  Substance
 use disorder

   Personality
     disorder
                  0.8 1.0 1.2 1.4 1.6   0.8 1.0 1.2 1.4 1.6   0.8 1.0 1.2 1.4 1.6   0.8 1.0 1.2 1.4 1.6   0.8 1.0 1.2 1.4 1.6   0.8 1.0 1.2 1.4 1.6

                  No HbA test           No LDL test             No Eye                  No                    Poor                    Poor
Odds ratio for:      done                  done               examination            Monitoring             glycemic                lipemic
                                                                 done                                        control                control
 313,586 Veteran Health Authority patients with diabetes
 76,799 (25%) had mental health conditions (1999)
                                                                        Frayne et al. Arch Intern Med. 2005;165:2631-2638
Monitoring patients DURING treatment with an atypical




                  Buckley PF et al Schizophrenia Research 79 (2005) 281– 288
Frequency of baseline assessment PRIOR to
initiating treatment with an atypical




               Buckley PF et al Schizophrenia Research 79 (2005) 281– 288
Summary of Monitoring Protocol

                                    Base
                                              4 wk      8 wk      12 wk     Quart       Ann       5 yr
                                    line

  Personal/fam. Hist.                 X                                                  X
  Weight (BMI)                        X         X         X         X         X
  Waist circum.                       X                                                  X
  Blood press.                        X                             X                    X
  Fasting plasma
  glucose
                                      X                             X                    X

  Fasting lipid profile               X                             X                              X
           American Diabetes Association and the American Psychiatric Association (ADA/ APA/AACE/NAASO, 2004).
Annual physical health checks
(NSF for mental health/NICE guidance)
   Blood pressure & weight/BMI

   Lifestyle advice (smoking/diet/exercise/alcohol/drugs)

   Urine/blood test to exclude diabetes

   Cholesterol check

   Medication side effect monitoring
    (Include thyroid function & creatinine if on lithium)

   Encourage screening in appropriate groups (cervical
    smears/mammography/hepatitis/HIV/high prolactin)

   Offer flu vaccination and contraceptive advice
N=6000 pre-guideline
N=18,000 post guideline
Screening for metabolic side effects in AO clients
Review of 1966 case records from 53 teams, Barnes et al (2007)


                       % with recorded        Documented                          Documented
                       measurement over       diagnosis                           treatment
                       last 12 months
    Blood pressure     26%                    Hypertension 6%                     48%


    Measure of         17%
    obesity

    Blood glucose      28%                    Diabetes 6%                         62%



    Plasma lipids      22%                    Dyslipidaemia                       37%
                                              6%


    All of the above   11%



                                       Slide credit: Dr Alan Farmer, Worcestershire Mental Health Partnership NHS Trust
Physical Screening of Psychiatric Patients
 57.6% of inpatients receive a comprehensive physical examination
     (Hodgson R, Adeyemo O. Physical examination performed by psychiatrists. International Journal of Psychiatry in Clinical
     Practice 2004;8:57-60.)



 No dental health target achieved in 428 people with Schizophrenia
   McCreadie RG, et al The dental health of people with schizophrenia. Acta Psychiatrica Scandinavica 2004;110:306-10)



 On screening at admission: 34% of older people had unrecognized
   medical disorders (Woo BKR, et al. Unrecognized medical disorders in older psychiatric inpatients in a senior
     behavioral health unit in a university hospital. Journal of Geriatric Psychiatry and Neurology 2003;16:121-5)



 On screening at admission: 29% had physical disorder (80%
   previously known 20% new diagnoses). These were contributory
   to diagnosis in 5.5% (Koran LM, et al Medical disorders among patients admitted to a public-sector
     psychiatric inpatient unit. Psychiatric Services 2002;53:1623-5.
6. Can inequalities be Improved?
NICE Schizophrenia guidelines

“The higher physical morbidity and mortality of service
 users with schizophrenia should be considered in all
 assessments.

“Whilst this would normally be expected to be the role
 of primary care services, secondary care services
 should nevertheless monitor these matters where
 they believe a service user may have little regular
 contact with primary care.”
                                                 NICE 2002
Longitudinal f/u and monitoring            Pr                     Pr                       Pr               Pr              Pr/Ps                            Pr/B/Ps               Pr/Ps               Pr/B/Ps                B2/Ps                          Ps/B2

                Extended B/P/S interventions               B1                     B1                       B                B               B                                B                     B2                  B2                     B2                             B2

                2nd level or higher meds                   Pr                     Ps                       Ps               Ps              Ps                               Ps                    Ps                  Ps                     Ps                             Ps

                Brief B/P/S interventions                  Pr/B1                  Pr/B1                    Pr/B1            Pr/B1           B1/Pr                            B/Pr                  B/Ps                B/Ps                   B/Ps                           B/Ps

                Initial Medications                        Pr                     Pr                       Pr               Pr/Ps           Pr/Ps                            Ps/Pr                 Ps                  Ps/Pr                  Ps                             Ps
Interventions




                Diagnosis/Comprehensive                    Pr                     Pr                       Pr               Pr/B1           B1/Pr                            B1//Pr                B/Ps                B/Ps                   B/Ps                           Ps
                P/S assessment


                Counseling/Psychoeducation                 Pr                     Pr                       Pr               Pr/B1           B1//Pr                           B1/Pr                 B/Ps                B                      B                              B

                Recognition/Limited P/S assessment         Pr                     Pr                       Pr               Pr              Pr                               Pr                    Pr                  Pr                     Pr                             Pr

                Primary Care For GMC                       Pr                     Pr                       Pr               Pr              Pr                               Pr                    Pr*                 Pr*                    Pr*                            Pr*
                                                                                  Substance Use Problems
                                                           Depressive Disorders




                                                                                                           Panic Disorder




                                                                                                                                                                                                                                               Severe Personality Disorder
                                                                                                                             Somatization



                                                                                                                                            Social, Specific Phobias
                                                                                                                                            Other - Anxiety Disorders e.g.



                                                                                                                                                                                 Substance Abuse



                                                                                                                                                                                                    Bipolar Disorder



                                                                                                                                                                                                                       Substance Dependence




                                                                                                                                                                                                                                                                              Schizophrenia
                Pr     Primary Care Provider
                       * = in specialty setting
                       B1 - Behavioral health
                B        Specialist in PCP setting
                       B2 - Behavorial Health
                         specialist in specialty
                Ps       setting
                       Psychiatrist




                Note - did not include child (e.g. ADHD)                                                                                                     Conditions/Populations
                geriatric (eg. dementia)
No Physical Health Without Mental Health

 Awareness of the link between physical and
    mental health

 Liaison Mental Health Services
 Engaging Patients and Carers
 Re-organisation, Quality & Commissioning
 Training and Education
Conclusions
Co-morbidity and mortality is high

Excess medical deaths > non-accidental deaths in MI

Medication influences morbidity & mortality

Quality of medical care is below usual standard

Physical health monitoring is poor

Guidelines accumulating but implementation lacking

Mais conteúdo relacionado

Destaque

Progressive Patient Care
Progressive Patient CareProgressive Patient Care
Progressive Patient CareNc Das
 
Legal aspect of medical care
Legal aspect of medical careLegal aspect of medical care
Legal aspect of medical careNc Das
 
Medico legal case
Medico legal caseMedico legal case
Medico legal caseNc Das
 
Hospital Administration
Hospital AdministrationHospital Administration
Hospital AdministrationFaseela Jaleel
 
12-Basic Financial Statement
12-Basic Financial Statement12-Basic Financial Statement
12-Basic Financial StatementWahyu Wijanarko
 
Medico –legal issues
Medico –legal issuesMedico –legal issues
Medico –legal issueschetan samra
 
Understanding financial statements
Understanding financial statementsUnderstanding financial statements
Understanding financial statementsGeni Whitehouse
 
Medical Director Responsibilities and Hospice Eligibility and Recertification
Medical Director Responsibilities and Hospice Eligibility and RecertificationMedical Director Responsibilities and Hospice Eligibility and Recertification
Medical Director Responsibilities and Hospice Eligibility and RecertificationTerri Hanlon Baker
 

Destaque (8)

Progressive Patient Care
Progressive Patient CareProgressive Patient Care
Progressive Patient Care
 
Legal aspect of medical care
Legal aspect of medical careLegal aspect of medical care
Legal aspect of medical care
 
Medico legal case
Medico legal caseMedico legal case
Medico legal case
 
Hospital Administration
Hospital AdministrationHospital Administration
Hospital Administration
 
12-Basic Financial Statement
12-Basic Financial Statement12-Basic Financial Statement
12-Basic Financial Statement
 
Medico –legal issues
Medico –legal issuesMedico –legal issues
Medico –legal issues
 
Understanding financial statements
Understanding financial statementsUnderstanding financial statements
Understanding financial statements
 
Medical Director Responsibilities and Hospice Eligibility and Recertification
Medical Director Responsibilities and Hospice Eligibility and RecertificationMedical Director Responsibilities and Hospice Eligibility and Recertification
Medical Director Responsibilities and Hospice Eligibility and Recertification
 

Mais de Alex J Mitchell

IPOS - Receipt of Psyccare-alex_j_mitchell_rotterdam
IPOS - Receipt of Psyccare-alex_j_mitchell_rotterdamIPOS - Receipt of Psyccare-alex_j_mitchell_rotterdam
IPOS - Receipt of Psyccare-alex_j_mitchell_rotterdamAlex J Mitchell
 
15th IPOS - Introducing CancerStories in Rotterdam, NL (Nov2013)
15th IPOS - Introducing CancerStories in Rotterdam, NL (Nov2013)15th IPOS - Introducing CancerStories in Rotterdam, NL (Nov2013)
15th IPOS - Introducing CancerStories in Rotterdam, NL (Nov2013)Alex J Mitchell
 
15th IPOS Debate on Screening for Distress by alex_j_mitchell in Rotterdam (N...
15th IPOS Debate on Screening for Distress by alex_j_mitchell in Rotterdam (N...15th IPOS Debate on Screening for Distress by alex_j_mitchell in Rotterdam (N...
15th IPOS Debate on Screening for Distress by alex_j_mitchell in Rotterdam (N...Alex J Mitchell
 
50 slides on Physical health Mental health Comorbidity (ajmitchell Nov2012))
50 slides on Physical health Mental health Comorbidity (ajmitchell Nov2012))50 slides on Physical health Mental health Comorbidity (ajmitchell Nov2012))
50 slides on Physical health Mental health Comorbidity (ajmitchell Nov2012))Alex J Mitchell
 
Alex J Mitchell Alcohol Detection by Clinician (Aug2012)
Alex J Mitchell Alcohol Detection by Clinician (Aug2012)Alex J Mitchell Alcohol Detection by Clinician (Aug2012)
Alex J Mitchell Alcohol Detection by Clinician (Aug2012)Alex J Mitchell
 
Top 10 Fastest Time trial Bikes of 2012
Top 10 Fastest Time trial Bikes of 2012Top 10 Fastest Time trial Bikes of 2012
Top 10 Fastest Time trial Bikes of 2012Alex J Mitchell
 
Illustration of Mental Health Clustering Calculator ajmitchell
Illustration of Mental Health Clustering Calculator ajmitchellIllustration of Mental Health Clustering Calculator ajmitchell
Illustration of Mental Health Clustering Calculator ajmitchellAlex J Mitchell
 
Weight diabetes and metabolic problems in patients taking atypical antipsycho...
Weight diabetes and metabolic problems in patients taking atypical antipsycho...Weight diabetes and metabolic problems in patients taking atypical antipsycho...
Weight diabetes and metabolic problems in patients taking atypical antipsycho...Alex J Mitchell
 
Tour of Britain London Stage (Sept11)
Tour of Britain London Stage (Sept11)Tour of Britain London Stage (Sept11)
Tour of Britain London Stage (Sept11)Alex J Mitchell
 
POCOG - The Future of Psycho-Oncology (Aug 2011)
POCOG - The Future of Psycho-Oncology (Aug 2011)POCOG - The Future of Psycho-Oncology (Aug 2011)
POCOG - The Future of Psycho-Oncology (Aug 2011)Alex J Mitchell
 
Suicide and desire for hastened death (edit)
Suicide and desire for hastened death (edit)Suicide and desire for hastened death (edit)
Suicide and desire for hastened death (edit)Alex J Mitchell
 
Combined PHQ9 and GAD7 (17 items)
Combined PHQ9 and GAD7 (17 items)Combined PHQ9 and GAD7 (17 items)
Combined PHQ9 and GAD7 (17 items)Alex J Mitchell
 
Psychological aspects of cancer care for students 2011 (Apr11)
Psychological aspects of cancer care for students 2011 (Apr11)Psychological aspects of cancer care for students 2011 (Apr11)
Psychological aspects of cancer care for students 2011 (Apr11)Alex J Mitchell
 
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)Alex J Mitchell
 
Rcpsych Workshop - Depression in medical settings (Mar11)
Rcpsych Workshop - Depression in medical settings (Mar11)Rcpsych Workshop - Depression in medical settings (Mar11)
Rcpsych Workshop - Depression in medical settings (Mar11)Alex J Mitchell
 
The Ant and the Lion - A Parody of NHS management
The Ant and the Lion - A Parody of NHS managementThe Ant and the Lion - A Parody of NHS management
The Ant and the Lion - A Parody of NHS managementAlex J Mitchell
 
COH Online- The future of screening for distress in cancer settings (February11)
COH Online- The future of screening for distress in cancer settings (February11)COH Online- The future of screening for distress in cancer settings (February11)
COH Online- The future of screening for distress in cancer settings (February11)Alex J Mitchell
 
Top 100 Most Cited People in Psychiatry (Mental Health) (Jan 2011) [aka Top 1...
Top 100 Most Cited People in Psychiatry (Mental Health) (Jan 2011) [aka Top 1...Top 100 Most Cited People in Psychiatry (Mental Health) (Jan 2011) [aka Top 1...
Top 100 Most Cited People in Psychiatry (Mental Health) (Jan 2011) [aka Top 1...Alex J Mitchell
 
Top 100 Papers & People in Psychiatry (Jan2011)
Top 100 Papers & People in Psychiatry (Jan2011)Top 100 Papers & People in Psychiatry (Jan2011)
Top 100 Papers & People in Psychiatry (Jan2011)Alex J Mitchell
 
Organizational chart of NHS staffing ratios 1999-2009
Organizational chart of NHS staffing ratios 1999-2009Organizational chart of NHS staffing ratios 1999-2009
Organizational chart of NHS staffing ratios 1999-2009Alex J Mitchell
 

Mais de Alex J Mitchell (20)

IPOS - Receipt of Psyccare-alex_j_mitchell_rotterdam
IPOS - Receipt of Psyccare-alex_j_mitchell_rotterdamIPOS - Receipt of Psyccare-alex_j_mitchell_rotterdam
IPOS - Receipt of Psyccare-alex_j_mitchell_rotterdam
 
15th IPOS - Introducing CancerStories in Rotterdam, NL (Nov2013)
15th IPOS - Introducing CancerStories in Rotterdam, NL (Nov2013)15th IPOS - Introducing CancerStories in Rotterdam, NL (Nov2013)
15th IPOS - Introducing CancerStories in Rotterdam, NL (Nov2013)
 
15th IPOS Debate on Screening for Distress by alex_j_mitchell in Rotterdam (N...
15th IPOS Debate on Screening for Distress by alex_j_mitchell in Rotterdam (N...15th IPOS Debate on Screening for Distress by alex_j_mitchell in Rotterdam (N...
15th IPOS Debate on Screening for Distress by alex_j_mitchell in Rotterdam (N...
 
50 slides on Physical health Mental health Comorbidity (ajmitchell Nov2012))
50 slides on Physical health Mental health Comorbidity (ajmitchell Nov2012))50 slides on Physical health Mental health Comorbidity (ajmitchell Nov2012))
50 slides on Physical health Mental health Comorbidity (ajmitchell Nov2012))
 
Alex J Mitchell Alcohol Detection by Clinician (Aug2012)
Alex J Mitchell Alcohol Detection by Clinician (Aug2012)Alex J Mitchell Alcohol Detection by Clinician (Aug2012)
Alex J Mitchell Alcohol Detection by Clinician (Aug2012)
 
Top 10 Fastest Time trial Bikes of 2012
Top 10 Fastest Time trial Bikes of 2012Top 10 Fastest Time trial Bikes of 2012
Top 10 Fastest Time trial Bikes of 2012
 
Illustration of Mental Health Clustering Calculator ajmitchell
Illustration of Mental Health Clustering Calculator ajmitchellIllustration of Mental Health Clustering Calculator ajmitchell
Illustration of Mental Health Clustering Calculator ajmitchell
 
Weight diabetes and metabolic problems in patients taking atypical antipsycho...
Weight diabetes and metabolic problems in patients taking atypical antipsycho...Weight diabetes and metabolic problems in patients taking atypical antipsycho...
Weight diabetes and metabolic problems in patients taking atypical antipsycho...
 
Tour of Britain London Stage (Sept11)
Tour of Britain London Stage (Sept11)Tour of Britain London Stage (Sept11)
Tour of Britain London Stage (Sept11)
 
POCOG - The Future of Psycho-Oncology (Aug 2011)
POCOG - The Future of Psycho-Oncology (Aug 2011)POCOG - The Future of Psycho-Oncology (Aug 2011)
POCOG - The Future of Psycho-Oncology (Aug 2011)
 
Suicide and desire for hastened death (edit)
Suicide and desire for hastened death (edit)Suicide and desire for hastened death (edit)
Suicide and desire for hastened death (edit)
 
Combined PHQ9 and GAD7 (17 items)
Combined PHQ9 and GAD7 (17 items)Combined PHQ9 and GAD7 (17 items)
Combined PHQ9 and GAD7 (17 items)
 
Psychological aspects of cancer care for students 2011 (Apr11)
Psychological aspects of cancer care for students 2011 (Apr11)Psychological aspects of cancer care for students 2011 (Apr11)
Psychological aspects of cancer care for students 2011 (Apr11)
 
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
 
Rcpsych Workshop - Depression in medical settings (Mar11)
Rcpsych Workshop - Depression in medical settings (Mar11)Rcpsych Workshop - Depression in medical settings (Mar11)
Rcpsych Workshop - Depression in medical settings (Mar11)
 
The Ant and the Lion - A Parody of NHS management
The Ant and the Lion - A Parody of NHS managementThe Ant and the Lion - A Parody of NHS management
The Ant and the Lion - A Parody of NHS management
 
COH Online- The future of screening for distress in cancer settings (February11)
COH Online- The future of screening for distress in cancer settings (February11)COH Online- The future of screening for distress in cancer settings (February11)
COH Online- The future of screening for distress in cancer settings (February11)
 
Top 100 Most Cited People in Psychiatry (Mental Health) (Jan 2011) [aka Top 1...
Top 100 Most Cited People in Psychiatry (Mental Health) (Jan 2011) [aka Top 1...Top 100 Most Cited People in Psychiatry (Mental Health) (Jan 2011) [aka Top 1...
Top 100 Most Cited People in Psychiatry (Mental Health) (Jan 2011) [aka Top 1...
 
Top 100 Papers & People in Psychiatry (Jan2011)
Top 100 Papers & People in Psychiatry (Jan2011)Top 100 Papers & People in Psychiatry (Jan2011)
Top 100 Papers & People in Psychiatry (Jan2011)
 
Organizational chart of NHS staffing ratios 1999-2009
Organizational chart of NHS staffing ratios 1999-2009Organizational chart of NHS staffing ratios 1999-2009
Organizational chart of NHS staffing ratios 1999-2009
 

Último

METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 

Último (20)

METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 

Open10 - Quality of Medical Care for Patients With Mental Illness - Do Patients Get A Raw Deal?

  • 1. Quality Of Medical Care for Patients With Mental Illness - Do Our Patients Get A Raw Deal? Alex Mitchell Oliver Lord Acknowledgements Darren Malone Caroline Carney-Doebbling Nasser Abdelmawla Brett Thombs Roy Ziegelstein Open meeting Jan 2010 Open meeting Jan 2010
  • 2. Contents 1. Mental Health & Physical Health Comorbidity & Mortality 2. Preventive Health Care Inequality Screening & prevention 3. Medical Health Care Inequality Procedures & prescribing 4. Implications for mortality Linking poor quality of care with mortality 5. Who is Monitoring? Guidelines & responsibility 6. Can inequalities be Improved? Interventions
  • 3. 1. Physical Health Comorbidity / Mortality
  • 4. Comorbid Physical Diagnoses in Elderly Depressed Patients 80 70 60 50 40 30 20 10 0 One Tw o Three+ None Proctor EK, et al (2003) American Journal of Geriatric Psychiatry;11:329- 38.
  • 5. 40 P hysical C omorbidity in S chiz ophrenia and D epression 35 30 Schizophrenia Depression 25 NHANES 20 15 10 Sokal 2004 J Nerv Ment Dis 192: 421– 427 5 0 Angina Ulcer Heart condition Any cancer Asthma Diabetes Chronic bronchitis Stroke Emphysema Myocardial infarction Hypertension Rheumatoid arthritis Osteoarthritis Coronary heart Weak/failing kidneys Congestive heart Liver problems disease failure NHANES - US Department of Health National Health and Nutrition Examination Survey , 1988 –1994
  • 6. Maine Study Results: Comparison of Health Disorders Between SMI & Non-SMI Groups of Health Disorders Between 80 SMI (N=9224) 70 59.4 Non-SMI (N=7352) 60 P e rc e n t M e m b e rs 50 40 33.9 30 28.6 28.4 30 22.8 21.7 20 16.5 11.5 11.1 10 6.3 5.9 0 Sk Ga Ob CO In Hy De D C He Pn L iv el e st r es P D f ect pe nt a iab e an c ar t eu e tal o-I it y iou rt e lD tes er D is mo r Di -C nte /D y s D nsi o iso ea n se on ne sti sl i pid ise n rd e se ia/ In f ase cti nal ase rs l ue nz ve a Colton CW, Manderscheid RW. Prev Chronic Dis [serial online] 2006 Apr [date cited]. Available from: from: URL:http://www.cdc.gov/pcd/issues/2006/apr/05_0180.htm
  • 7. Lawrence & Coghlan N S W Public Health Bull 2002; 13(7): 155–158 n=240,000
  • 8. Mortality and Depression - IHD Psychosomatic Med (2004) Barth et al
  • 9. Schizophrenia – all cause mortality > > > > Saha (2007) AGP Pooled estimate=2.50 (95% CI=2.18-2.83)
  • 10. Five-year Mortality rates 30 People with schizophrenia 28% People without schizophrenia 25 22% 20 19% 15 12% 10 9% 8% 5 0 CHD Diabetes Stroke Hippisley-Cox J et al (2006) A comparison of survival rates for people with mental health problems and the remaining population with specific conditions. Disability Rights Commission. Equal treatment: closing the gap, July 2006 Slide credit: Dr Alan Farmer, Worcestershire Mental Health Partnership NHS Trust
  • 11. Mortality & Mental illness: Caveat Has the mortality gap been reducing? Has modern medication improved the situation?
  • 14. Effect of Medication Varies according to Schizophrenia Dementia Depression
  • 15.
  • 16.
  • 17.
  • 18. Smoller et al (2010) Ann Int Med SSRI associated with increased all-cause mortality HR 1.32 95% CI, 1.10-1.59 SSRI associated with increased stroke HR 1.45, 95% CI, 1.08-1.97 TCA associated with increased risk of all-cause mortality HR,1.67 [95% CI, 1.33-2.09
  • 19. Mental Illness => High Medical Morbidity & Mortality Therefore do we? i Improve preventive screening ii Enhance quality of routine medical care iii Ensure adequate physical health medication iv Help with treatment adherence (NICE) v Monitor physical health issues
  • 20. 2. Preventive Health Care Inequality
  • 21. Screening activities Mammography => use as an example (over) Pap. Smear Vaccinations Lifestyle counselling Blood pressure Bowel cancer screening Breast examination PSA Osteoporosis Hepatitis & HIV
  • 22. Mammography USPSTF recommendations Screening mammography with or without clinical breast exam (CBE) every 1-2 years starting at age 40 Insufficient evidence for or against CBE alone UK NSC (England) Age 50-70 every 3 years
  • 23. Mammography and Depression Over 40 years Druss (2008)US n= OR of not having mammogram OR 1.22 (95% CI 1.18-1.26). This difference was even greater if the depression was untreated adj.OR 1.32 ( 1.22- 1.42). Those being treated in secondary care were more likely to have not had a mammogram than those treated in primary care adjusted OR 1.22(95% CI 1.03-1.44). Pirraglia (2004) US n=3302 Those who screened positive for depression were less likely to have a mammogram in the subsequent year adj. OR 0.84 (95% CI 0.73-0.97). Stecker et trend to increased use in Depression vs Hypertensive controls Green and Pope, US 2000, n=589 showed increased rates of mammography Over 65 year olds 2 US studies showing no difference n=3864 Over 50 year olds Canadian study showed no difference, n =1,868 European study showed no difference, n = 15,380
  • 24. Mammography and any mental disorder Werenke (2006) UK n= 533,340 no difference for mental health service users but those on enhanced care were less likely to attend (OR 0.4 95% CI 0.29- 0.55). more than 2 admissions to a mental health hospital were less likely to attend for mammography (OR 0.65, 95% CI, 0.49-0.85). Carney and Jones (2006) US n= 191356, 5 year study period: high risk OR 0.38 (95% CI 0.33-0.43), moderate risk 0.62 (95% CI 0.59-0.66). last 2 years: low risk 0.95(95% CI 0.92-.99), moderate risk OR 0.71 (95% CI 0.66-0.75), high risk OR 0.63 (95% CI 0.53-0.75). Lasser (2003) US n=526 no difference for mammography in last 2 years Steiner (1998) US n=64 no difference Iezzoni (2001) US n=11399 a trend to reduced use of mammography (SMI) in the last 2 yrs OR 0.6 (95% CI 0.4 – 1.1)
  • 25. Mammography and Schizophrenia Chochinov (2009) Canada n=110,240 In comparison to the general population (without schizophrenia) (n=108,792), women with schizophrenia (n=1448) OR 0.64 of mammography in the selected two year period. Carney and Jones (2006) n=191,356 No difference over five years less likely in the last two years OR 0.31 (95% CI 0.12-0.83). Werenke (2006) UK n= 533,340 Those with a diagnosis of psychosis were the least likely to attend for mammography OR 0.33 (95% CI 0.18-0.61) Lindamer (2003) US n=116 (Convenience sample) in last 2 years 68% of women with psychotic disorder 98% of respondents to advertisement Druss (2002) US less likely to have had a mammogram in last 2 years (for women aged 50-69 years) adjusted OR 0.78(95% CI 0.67-0.91).
  • 26. 3. Medical Health Care Inequality Medical monitoring eg HBA1c Medical procedures eg CABG Medical prescribing eg Insulin
  • 27. Quality of Care MI vs No MI 27 examined receipt of medical care in those with and without mental illness 19/27 showed deficits in care 10 examined medical care in those with and without substance use disorder (or dual-diagnosis 10/10 showed deficits in care
  • 28. Relevant Primary Data Studies 26 studies 1 study 2 studies 10 studies 9 studies 4 studies Studies examining Cancer Studies examining Studies examining Studies examining Studies examining Care HIV Care Diabetes Care Cardiovascular care General Medical Care Goodwin JS et al. 2004 Palepu A et al. 2006. J Sub Abuse Desai M et al. 2002 Druss B et al 2000. Redelmeier D et al. 1998 N Eng J JAGS 52; 106-111. Treat. In Press * Am J Psych. 159;1584-90 * JAMA 283; 506-511 * Med. 338; 1516-1520 Bogart et al 2006 AIDS Patient Lin EH et al. 2004 Diabetes Care Young J et al 2000. Desai M et al. 2002 J Gen Intern Care & STDs 20(3) 175-182 27(9):2154-60. JAMA 28, 3198-9 * Med.17; 556-560 * Dixon L 2004. Psychiatric Druss BD et al. 2001. Arch Gen Cradock-O’Leary,et al 2002. services. 55;892-900 ª psych. 58; 565-572 * Psychia Serv 53;874-8 * Jones L et al. 2004. Medical Desai MM, et a; 2002. Dickerson F et al 2003 care.42;1167-1175 JNMD 190(1), 51-53 * Psychiatric Serv 41; 560-570. Frayne S et al. 2006.Arch Int Lawrence D et al 2003. med. 165;2631-2638 Br J Psych 182;31-36. Krein et al 2006 Psychia Serv Petersen LA et al 2003 57:1016–1021 Health Serv Res 38; 41-63. Sullivan et al. 2006 Psychiatr Jones L et al. 2005. Psychosom Serv 57:1126–1131 Med 67; 568-76. Weiss AP. et al 2006 Wang P et al. 2005. * Studies reporting substance Psychiatr Serv 57(8):1145-1152 Hypertension. 46; 273-279 abuse and/or mental illness Kreyenbuhl J et al 2006 Hippisley-Cox et al. 2007 Heart JNMD 194:404–410 ª 93:1256–1262 a Studies reporting on the same data set Goldberg RW et al. 2007 Psychiatr Serv 58:536–543 ª
  • 29. Quality of Medical Treatment i Procedures
  • 30.
  • 31. Meta-Analysis of Procedure Rate (PCI) after Myocardial Infarction Any Mental illness HR = 0.86 (0.80-0.92)
  • 32. Meta-Analysis of Procedure Rate (PCI) after Myocardial Infarction Schizophrenia HR = 0.53 (0.44 – 0.64)
  • 33. Quality of Medical Treatment i Medication
  • 34. Inequality of Prescribed Meds ii Medication by Diagnosis OR =0.92 OR =0.68 OR =0.72 SMI Schz Affective
  • 35. Inequality of Prescribed Meds ii Medication by Drug OR =0.99 OR =0.79 ns OR =0.83 OR =0.84 ns
  • 36. Quality of Medical Treatment ii Medication by Drug OR =0.94 OR =0.96 ns
  • 37. 4. Implication for Mortality
  • 38.
  • 39.
  • 40. 5. Who Is Monitoring Physical Issues? Medical Colleagues Mental health Primary care
  • 41. Disparities in care: impact of mental illness on diabetes management Depression Anxiety Psychosis Mania Substance use disorder Personality disorder 0.8 1.0 1.2 1.4 1.6 0.8 1.0 1.2 1.4 1.6 0.8 1.0 1.2 1.4 1.6 0.8 1.0 1.2 1.4 1.6 0.8 1.0 1.2 1.4 1.6 0.8 1.0 1.2 1.4 1.6 No HbA test No LDL test No Eye No Poor Poor Odds ratio for: done done examination Monitoring glycemic lipemic done control control 313,586 Veteran Health Authority patients with diabetes 76,799 (25%) had mental health conditions (1999) Frayne et al. Arch Intern Med. 2005;165:2631-2638
  • 42. Monitoring patients DURING treatment with an atypical Buckley PF et al Schizophrenia Research 79 (2005) 281– 288
  • 43. Frequency of baseline assessment PRIOR to initiating treatment with an atypical Buckley PF et al Schizophrenia Research 79 (2005) 281– 288
  • 44. Summary of Monitoring Protocol Base 4 wk 8 wk 12 wk Quart Ann 5 yr line Personal/fam. Hist. X X Weight (BMI) X X X X X Waist circum. X X Blood press. X X X Fasting plasma glucose X X X Fasting lipid profile X X X American Diabetes Association and the American Psychiatric Association (ADA/ APA/AACE/NAASO, 2004).
  • 45. Annual physical health checks (NSF for mental health/NICE guidance) Blood pressure & weight/BMI Lifestyle advice (smoking/diet/exercise/alcohol/drugs) Urine/blood test to exclude diabetes Cholesterol check Medication side effect monitoring (Include thyroid function & creatinine if on lithium) Encourage screening in appropriate groups (cervical smears/mammography/hepatitis/HIV/high prolactin) Offer flu vaccination and contraceptive advice
  • 47. Screening for metabolic side effects in AO clients Review of 1966 case records from 53 teams, Barnes et al (2007) % with recorded Documented Documented measurement over diagnosis treatment last 12 months Blood pressure 26% Hypertension 6% 48% Measure of 17% obesity Blood glucose 28% Diabetes 6% 62% Plasma lipids 22% Dyslipidaemia 37% 6% All of the above 11% Slide credit: Dr Alan Farmer, Worcestershire Mental Health Partnership NHS Trust
  • 48. Physical Screening of Psychiatric Patients 57.6% of inpatients receive a comprehensive physical examination (Hodgson R, Adeyemo O. Physical examination performed by psychiatrists. International Journal of Psychiatry in Clinical Practice 2004;8:57-60.) No dental health target achieved in 428 people with Schizophrenia McCreadie RG, et al The dental health of people with schizophrenia. Acta Psychiatrica Scandinavica 2004;110:306-10) On screening at admission: 34% of older people had unrecognized medical disorders (Woo BKR, et al. Unrecognized medical disorders in older psychiatric inpatients in a senior behavioral health unit in a university hospital. Journal of Geriatric Psychiatry and Neurology 2003;16:121-5) On screening at admission: 29% had physical disorder (80% previously known 20% new diagnoses). These were contributory to diagnosis in 5.5% (Koran LM, et al Medical disorders among patients admitted to a public-sector psychiatric inpatient unit. Psychiatric Services 2002;53:1623-5.
  • 49. 6. Can inequalities be Improved?
  • 50. NICE Schizophrenia guidelines “The higher physical morbidity and mortality of service users with schizophrenia should be considered in all assessments. “Whilst this would normally be expected to be the role of primary care services, secondary care services should nevertheless monitor these matters where they believe a service user may have little regular contact with primary care.” NICE 2002
  • 51.
  • 52. Longitudinal f/u and monitoring Pr Pr Pr Pr Pr/Ps Pr/B/Ps Pr/Ps Pr/B/Ps B2/Ps Ps/B2 Extended B/P/S interventions B1 B1 B B B B B2 B2 B2 B2 2nd level or higher meds Pr Ps Ps Ps Ps Ps Ps Ps Ps Ps Brief B/P/S interventions Pr/B1 Pr/B1 Pr/B1 Pr/B1 B1/Pr B/Pr B/Ps B/Ps B/Ps B/Ps Initial Medications Pr Pr Pr Pr/Ps Pr/Ps Ps/Pr Ps Ps/Pr Ps Ps Interventions Diagnosis/Comprehensive Pr Pr Pr Pr/B1 B1/Pr B1//Pr B/Ps B/Ps B/Ps Ps P/S assessment Counseling/Psychoeducation Pr Pr Pr Pr/B1 B1//Pr B1/Pr B/Ps B B B Recognition/Limited P/S assessment Pr Pr Pr Pr Pr Pr Pr Pr Pr Pr Primary Care For GMC Pr Pr Pr Pr Pr Pr Pr* Pr* Pr* Pr* Substance Use Problems Depressive Disorders Panic Disorder Severe Personality Disorder Somatization Social, Specific Phobias Other - Anxiety Disorders e.g. Substance Abuse Bipolar Disorder Substance Dependence Schizophrenia Pr Primary Care Provider * = in specialty setting B1 - Behavioral health B Specialist in PCP setting B2 - Behavorial Health specialist in specialty Ps setting Psychiatrist Note - did not include child (e.g. ADHD) Conditions/Populations geriatric (eg. dementia)
  • 53. No Physical Health Without Mental Health Awareness of the link between physical and mental health Liaison Mental Health Services Engaging Patients and Carers Re-organisation, Quality & Commissioning Training and Education
  • 54. Conclusions Co-morbidity and mortality is high Excess medical deaths > non-accidental deaths in MI Medication influences morbidity & mortality Quality of medical care is below usual standard Physical health monitoring is poor Guidelines accumulating but implementation lacking